Fuller & Thaler Asset Management
ABMD

Fuller & Thaler Asset Management’s Abiomed Inc ABMD Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-500
Closed -$45K – 901
2015
Q4 		$45K Sell
500
-123,160
-100% -$10.5M ﹤0.01% 651
2015
Q3 		$11.5M Sell
123,660
-8,700
-7% -$767K 0.3% 83
2015
Q2 		$8.7M Sell
132,360
-18,400
-12% -$1.22M 0.25% 93
2015
Q1 		$10.8M Buy
+150,760
New +$8.18M 0.34% 76

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fuller & Thaler Asset Management's ABMD Position: Q1 2016 in Review

Fuller & Thaler Asset Management sold out of Abiomed Inc (ABMD) in Q1 2016, closing a stake of 500 shares — an estimated $45K sold.

Fuller & Thaler Asset Management first reported a position in ABMD in Q1 2015 and held it in 4 quarters. The position peaked at $11.5M in Q3 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

  • Fuller & Thaler Asset Management reported no remaining Abiomed Inc position as of Q1 2016 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 500 Abiomed Inc shares in Q1 2016, an estimated $45K.
  • Fuller & Thaler Asset Management first reported a position in Abiomed Inc in Q1 2015 and held it in 4 quarters.
  • Fuller & Thaler Asset Management's Abiomed Inc position peaked at $11.5M in Q3 2015.
  • 274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2016, filed 12 May 2016.